Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Walk on: A Community-based Approach to Increase Physical Activity Among Men Treated for Colorectal Cancer

13 septembre 2018 mis à jour par: Jennifer Brunet, University of Ottawa

Walk on: A Community-based Approach to Promote Participation in Physical Activity Among Men Treated for Colorectal Cancer

In Canada, over 102,900 men are diagnosed with cancer each year. Of these, 81,000 are diagnosed with colorectal cancer and an estimated 65% are expected to survive the disease for at least 5 years. Men who have completed treatment for colorectal cancer face many adverse physical, cognitive, psychological, and social effects. The Wellness Beyond Cancer Program at The Ottawa Hospital is a cancer survivorship program that helps people who have completed treatment for cancer, including men diagnosed with colorectal cancer, manage these effects. The Wellness Beyond Cancer Program does this through education and referral to supportive care services and programs offered throughout the city of Ottawa.

Group-based physical activity programs are one of the varied services and programs available to adults diagnosed with cancer in Ottawa. Such programs are offered through the Ottawa Regional Cancer Foundation (http://www.ottawacancer.ca) and Breast Cancer Action Ottawa (http://bcaott.ca). Research on these programs show that group-based physical activity can improve disease and treatment-related effects while promoting overall quality of life amongst women with cancer. However, few of these programs have targeted men, even though their needs and preferences have been shown to be very different from women. While men diagnosed with colorectal cancer might also benefit from group-based physical activity programs offered in the community, it is not known if such programs would effectively reach them and what the impact would be on their quality of life after cancer treatment.

It is believed that a men's group-based walking program could be an effective way to reach men and promote quality of life after cancer treatment. Therefore, a sustainable 8-week group-based walking program was developed. This project will seek to explore the feasibility and potential benefits of the program among men who have completed treatment for colorectal cancer and who are referred to the program from staff at the Wellness Beyond Cancer Program in a prospective single-arm trial.

Aperçu de l'étude

Statut

Retiré

Les conditions

Intervention / Traitement

Type d'étude

Interventionnel

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Ontario
      • Ottawa, Ontario, Canada, K1N 6N5
        • University of Ottawa

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Homme

La description

Inclusion Criteria:

  1. Men 18 years of age or older;
  2. Have completed treatment for colorectal cancer <1 year;
  3. Willing to provide informed consent to participate in this study and willing to follow the study protocol;
  4. Have the ability to walk without the use of an assistive device (including a cane) or the help of another person;
  5. Able to read and understand English;
  6. Medically cleared to participate in the walking program as determined by their referring Wellness Beyond Cancer Program healthcare provider.

Exclusion Criteria:

  1. Congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, uncontrolled angina, uncontrolled arrhythmia, myocardial infarction, major heart surgery, stroke, or pulmonary embolus;
  2. Uncontrolled hypertension (systolic blood pressure>200 mm Hg and/or diastolic blood pressure >110 mm Hg);
  3. The use of supplemental oxygen;
  4. Severe arthritis (i.e., osteoarthritis or rheumatoid arthritis);
  5. History of chest pain or severe shortness of breath either at rest or when engaging in physical activity;
  6. Hip fracture, hip or knee replacement in the past 6 months;
  7. Currently enrolled in another study involving a physical activity intervention.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Group-based walking
Participants will engage in one supervised outdoor group-based walking session per week for the 8 week program.
The walking prescription will be progressive in nature. The program will begin with participants walking for approximately 20 minutes in weeks 1-3. This will gradually increase to approximately 30 minutes in weeks 4-6. Finally, this will increase to 45-60 minutes in weeks 7-8. The program will promote walking at a moderate intensity as assessed by Borg's Rating of Perceived Exertion scale. Each session will be preceded by a brief warm-up and followed by a brief cool-down period.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Recruitment rates
Délai: Through study completion, an average of 8 weeks
The number of men who enrol in the study out of the number who are referred.
Through study completion, an average of 8 weeks
Retention rates
Délai: Through study completion, an average of 8 weeks
The number of men who complete the intervention and all scheduled assessments.
Through study completion, an average of 8 weeks
Adherence rates
Délai: Through study completion, an average of 8 weeks
The number of walking sessions men engage in out of the total recommended as part of the intervention.
Through study completion, an average of 8 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Physical Activity Behaviour: Leisure Time Exercise Questionnaire (Godin & Shephard, 1985)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported physical activity (over the past 7 days) from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Quality of Life: Functional Assessment of Cancer Therapy (FACT)-Colorectal (Ward et al., 1999; Yost et al. 2005)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported quality of life from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Cognitive Functioning: FACT-Cognitive Function (Wagner et al., 2004)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported cognitive functioning from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Affect: Positive and Negative Affect Schedule (Watson et al., 1988)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported affect from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Depression: Center for Epidemiologic Studies Depression Scale 10-item Revised (Eaton et al., 2004; Radloff, 1977)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported depressive symptoms from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Social Support: Relatedness to Others in Physical Activity Scale (Wilson & Bengoechea, 2010)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported perceptions of social support from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Physical Self-Perceptions: Physical Self Description Questionnaire Short-Form (Marsh et al., 2010)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported physical competence, confidence, and self-esteem from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Stress: Perceived Stress Scale (Cohen et al., 1982)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported perceptions of stress from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Change in Fatigue: Functional Assessment of Chronic Illness Therapy-Fatigue Scale (Yellen et al., 1997)
Délai: Baseline (week 0) and post-intervention (week 8)
Change in participants' self-reported perceptions of fatigue from baseline to post-intervention.
Baseline (week 0) and post-intervention (week 8)
Participants' Overall Experiences: Qualitative Interviews
Délai: Post-intervention (week 8)
Participants' perspectives on how the intervention contributed to their behavioural, physical, psychological and social functioning, as well as their overall quality of life.
Post-intervention (week 8)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Jennifer Brunet, PhD, University of Ottawa

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

5 octobre 2017

Achèvement primaire (Anticipé)

30 septembre 2018

Achèvement de l'étude (Anticipé)

30 septembre 2018

Dates d'inscription aux études

Première soumission

23 juillet 2017

Première soumission répondant aux critères de contrôle qualité

25 juillet 2017

Première publication (Réel)

28 juillet 2017

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

17 septembre 2018

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 septembre 2018

Dernière vérification

1 septembre 2018

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Cancer colorectal

Essais cliniques sur Group-based walking

3
S'abonner